Obesity
| Weight loss
Obesity
Weight loss
Tirzepatide-Induced Weight Loss Is Associated With Body Composition Improvements Across Age Groups
book_2
Source:
ObesityWeek 2022 - Session summary
calendar_today
Published on Medfyle:
November 2022
import_contacts
4
min
In this medfyle
Tirzepatide is associated with significant weight loss in adults with obesity that is consistent in all age groups.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of an oral session given at the ObesityWeek® 2022 and presented by:
Robert Kushner, MD
Northwestern University Feinberg School of Medicine
Chicago, IL, USA
The content is produced by Infomedica. The presenting authors of the original session had no part in the creation of this conference summary.
